Annual Drug Patent Expirations for ZEPOSIA
Zeposia is a drug marketed by Bristol and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
This drug has one hundred and thirty-two patent family members in thirty-two countries.
The generic ingredient in ZEPOSIA is ozanimod hydrochloride. One supplier is listed for this compound. Additional details are available on the ozanimod hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com